Status:
ENROLLING_BY_INVITATION
EMLA Cream as Analgesic for Outpatient Gynecological Procedures
Lead Sponsor:
CAMC Health System
Conditions:
Pain
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy,...
Detailed Description
Gynecologic outpatient procedures such as intra-uterine device (IUD) insertion, hysteroscopy and endometrial biopsies (EMB) have no standard of care for pain management. This has resulted in acute pai...
Eligibility Criteria
Inclusion
- Patient will undergo one of the following procedures: intra-uterine device insertion, hysteroscopy, or endometrial biopsies
Exclusion
- Known hypersensitivity to amide anesthetics
- Pre-existing methemoglobinemia
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05970354
Start Date
September 15 2023
End Date
February 28 2025
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charleston Area Medical Center Institute for Academic Medicine
Charleston, West Virginia, United States, 25302